TuHURA Biosciences (HURA) Short term Debt (2012 - 2023)
TuHURA Biosciences' (HURA) quarterly Short term Debt came in at $298000.0 in Q2 2023, down 58.67% year-on-year from $721000.0 in Q2 2022, and up 65.56% quarter-over-quarter from $180000.0 in Q1 2023.
TuHURA Biosciences (HURA) Short term Debt (2012 - 2023) Analysis & Trends
TuHURA Biosciences' Short term Debt history runs 12 years deep, the most recent figure standing at $298000.0 for Q2 2023.
- On a quarterly basis, Short term Debt fell 58.67% year-over-year to $298000.0 in Q2 2023; TTM through Jun 2023 was $298000.0, a 58.67% decrease from a year earlier, with the FY2023 full-year figure at $298000.0, down 58.67% from the prior year.
- Short term Debt improved to $298000.0 in Q2 2023 per HURA's latest filing, from $180000.0 in the prior quarter.
- Across five years, Short term Debt topped out at $721000.0 in Q2 2022 and bottomed at $113240.0 in Q1 2019.
- The 5-year median for Short term Debt is $449500.0 (2020), against an average of $416277.9.
- Across the five-year window, Short term Debt surged 161.55% in 2020 and slumped 60.7% in 2023, its largest moves.
- Year by year, Short term Debt stood at $276674.0 in 2019, then gained by 4.6% to $289397.0 in 2020, then soared by 87.63% to $543000.0 in 2021, then increased by 0.92% to $548000.0 in 2022, then plunged by 45.62% to $298000.0 in 2023.
- Per Business Quant, the three latest HURA Short term Debt figures stand at $298000.0 (Q2 2023), $180000.0 (Q1 2023), and $548000.0 (Q4 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 298,000.00 |
| Mar 31, 2023 | 180,000.00 |
| Dec 31, 2022 | 548,000.00 |
| Sep 30, 2022 | 573,000.00 |
| Jun 30, 2022 | 721,000.00 |
| Mar 31, 2022 | 458,000.00 |
| Dec 31, 2021 | 543,000.00 |
| Sep 30, 2021 | 491,000.00 |
| Jun 30, 2021 | 561,000.00 |
| Mar 31, 2021 | 503,000.00 |
| Dec 31, 2020 | 289,397.00 |
| Sep 30, 2020 | 441,000.00 |
| Jun 30, 2020 | 664,000.00 |
| Mar 31, 2020 | 296,184.00 |
| Dec 31, 2019 | 276,674.00 |
| Sep 30, 2019 | 211,300.00 |
| Jun 30, 2019 | 325,208.00 |
| Mar 31, 2019 | 113,240.00 |
| Dec 31, 2018 | 152,325.00 |
| Sep 30, 2018 | 168,103.00 |